Cargando…
Autoantibodies in cryptogenic fibrosing alveolitis
The pathogenesis of cryptogenic fibrosing alveolitis (CFA) involves injury, an immune/inflammatory response and fibrosis. The cause of the injury is unknown, but the identification of serum autoantibodies makes an autoimmune aetiology attractive. The core study on which this commentary is based used...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59568/ https://www.ncbi.nlm.nih.gov/pubmed/11686865 http://dx.doi.org/10.1186/rr38 |
_version_ | 1782120074515054592 |
---|---|
author | Singh, Suveer du Bois, Ron |
author_facet | Singh, Suveer du Bois, Ron |
author_sort | Singh, Suveer |
collection | PubMed |
description | The pathogenesis of cryptogenic fibrosing alveolitis (CFA) involves injury, an immune/inflammatory response and fibrosis. The cause of the injury is unknown, but the identification of serum autoantibodies makes an autoimmune aetiology attractive. The core study on which this commentary is based used novel cloning and serum screening technologies in order to identify new public and private autoantibodies in sera from 12 patients with CFA. Largely negative conclusions were drawn from that study. However, we suggest that the prevalence of autoantibodies may have been underestimated, that the study was timely and that this approach is worth pursuing further. |
format | Text |
id | pubmed-59568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-595682001-11-06 Autoantibodies in cryptogenic fibrosing alveolitis Singh, Suveer du Bois, Ron Respir Res Commentary The pathogenesis of cryptogenic fibrosing alveolitis (CFA) involves injury, an immune/inflammatory response and fibrosis. The cause of the injury is unknown, but the identification of serum autoantibodies makes an autoimmune aetiology attractive. The core study on which this commentary is based used novel cloning and serum screening technologies in order to identify new public and private autoantibodies in sera from 12 patients with CFA. Largely negative conclusions were drawn from that study. However, we suggest that the prevalence of autoantibodies may have been underestimated, that the study was timely and that this approach is worth pursuing further. BioMed Central 2001 2001-02-21 /pmc/articles/PMC59568/ /pubmed/11686865 http://dx.doi.org/10.1186/rr38 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Commentary Singh, Suveer du Bois, Ron Autoantibodies in cryptogenic fibrosing alveolitis |
title | Autoantibodies in cryptogenic fibrosing alveolitis |
title_full | Autoantibodies in cryptogenic fibrosing alveolitis |
title_fullStr | Autoantibodies in cryptogenic fibrosing alveolitis |
title_full_unstemmed | Autoantibodies in cryptogenic fibrosing alveolitis |
title_short | Autoantibodies in cryptogenic fibrosing alveolitis |
title_sort | autoantibodies in cryptogenic fibrosing alveolitis |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59568/ https://www.ncbi.nlm.nih.gov/pubmed/11686865 http://dx.doi.org/10.1186/rr38 |
work_keys_str_mv | AT singhsuveer autoantibodiesincryptogenicfibrosingalveolitis AT duboisron autoantibodiesincryptogenicfibrosingalveolitis |